US EditionPublished • loading... • Updated
Zydus Launches Semaglutide Injection in an Innovative, Reusable Multi-Dose Pen Device in India
Summary by THE TIMES OF BENGAL
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Zydus Launches Semaglutide Injection in an Innovative, Reusable Multi-Dose Pen Device in India
Business Wire India The novel pen device will be available for patients in a prefilled cartridge administered using a patient-friendly reusable pen for which the company has exclusive rights The drug will be launched under the brand names – SEMAGLYN TM, MASHEMA TM and ALTERME TM Zydus Lifesciences Limited (including its subsidiaries, hereafter referred to as “Zydus”), an innovation-led global lifesciences company, has launched Semaglutide Injec…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
